USPH - Massive Insider Trade At US Physical Therapy | Benzinga
A substantial insider sell was reported on December 14, by Clayton Trier, Director at US Physical Therapy (NYSE:USPH), based on the recent SEC filing.
What Happened: Trier's decision to sell 1,170 shares of US Physical Therapy was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday. The total value of the sale is $107,944.
Tracking the Friday's morning session, US Physical Therapy shares are trading at $92.44, showing a down of 0.0%.
Get to Know US Physical Therapy Better
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
US Physical Therapy's Financial Performance
Revenue Growth: US Physical Therapy displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 7.45%. This indicates ...